Risks in new drug development: Approval success rates for investigational drugs

被引：298
|
作者：
DiMasi, JA [1 ]
机构：
[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 05期
关键词：
D O I：
10.1067/mcp.2001.115446
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：297 / 307
页数：11
相关论文
共 50 条
  • [31] FOOD-AND-DRUG-ADMINISTRATION REQUIREMENTS FOR APPROVAL OF NEW ANTICANCER DRUGS
    JOHNSON, JR
    TEMPLE, R
    CANCER TREATMENT REPORTS, 1985, 69 (10): : 1155 - &
  • [32] Investigational drugs in development for Hepatitis D
    Rizzetto, Mario
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (09) : 999 - 1005
  • [33] Buprenorphine implants: a model for expedited development and approval of new drugs
    Guarnieri, Michael
    Kedda, Jayanidhi
    Tyler, Betty
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (01) : 83 - 88
  • [34] PLANNING RESEARCH AND DEVELOPMENT OF NEW DRUGS TO ASSURE REGULATORY APPROVAL
    HURLEY, FL
    FOOD AND DRUG LAW JOURNAL, 1984, 39 (03): : 312 - 317
  • [35] INVESTIGATIONAL DRUGS AND DRUG-USE POLICY
    LEE, H
    HOSPITAL FORMULARY, 1986, 21 (05): : 617 - &
  • [36] NEW DRUG APPROVAL
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2009, 109 (10) : 32 - 32
  • [37] Recent Trends and Success Factors in Reducing the Lag Time to Approval of New Drugs in Japan
    Honig, P. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (05) : 466 - 469
  • [38] INVESTIGATIONAL EXEMPTION PROCEDURES FOR NEW DRUGS
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 213 (11): : 1902 - &
  • [39] New investigational drugs for androgenetic alopecia
    Duarte de Sousa, Isabel Cristina Valente
    Tosti, Antonella
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (05) : 573 - 589
  • [40] Investigational new drugs for allergic rhinitis
    Ricketti, Peter A.
    Alandijani, Sultan
    Lin, Chen Hsing
    Casale, Thomas B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (03) : 279 - 292
12345